Company

Biomind Labs, Inc.

Headquarters: Toronto, ON, Canada

Employees: 6

CEO: Mr. Alejandro Antalich

NEO: BMND +40.48%

Detailed Description

Biomind Labs Inc., a biotech research and development company, focuses on developing novel pharmaceutical drugs and nanotech delivery systems for various psychiatric and neurological conditions. The company is developing BMND02 – N, N-dimethytryptamine that is in Phase II clinical trials for use in the treatment of depression; and BMND01 – Ayahuasca, a product candidate in pre-clinical trials for use in the treatment of smoking addiction. Its product candidates in evaluation stage include BMND03 – Psilocybin for treating chronic pain; BMND04 – Mescaline for treating eating disorders and neurodegenerative diseases; and BMND05 – 5-MeO-DMT, an anti-inflammatory product. The company is based in Toronto, Canada.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Biomind Labs, Inc. has the following listings and related stock indices.


Stock: NEO: BMND wb_incandescent

Details

Headquarters:

217 Queen Street West

Suite 40

Toronto, ON None

Canada